OpenLB
Open Library of Bioscience
Advanced Search
Current opinion in endocrinology, diabetes, and obesity
Mar 25, 2025;

Obesity, insulin resistance and fertility: unresolved questions and emerging insights.

Kavita Narula, Julia S Kenkre, Wann Jia Loh, Tricia Tan
Author Information
  1. Kavita Narula: Imperial College Healthcare NHS Trust.
  2. Julia S Kenkre: Imperial College London Division of Experimental Medicine: Imperial College London Faculty of Medicine, London, UK.
  3. Wann Jia Loh: Changi General Hospital, Singapore.
  4. Tricia Tan: Imperial College London Division of Experimental Medicine: Imperial College London Faculty of Medicine, London, UK.
PMID: 40125660 DOI: 10.1097/MED.0000000000000907

Abstract

PURPOSE OF REVIEW: Obesity significantly impacts fertility in women, contributing to hormonal imbalances, ovulatory dysfunction, and poor reproductive outcomes. This is especially pronounced in polycystic ovary syndrome (PCOS), where obesity and insulin resistance exacerbate fertility challenges. Moreover, obesity is a risk factor for type 2 diabetes (T2D) and gestational diabetes (GDM), further complicating reproductive health. Effective weight loss interventions before conception are essential to improve fertility and reduce the risks of adverse perinatal outcomes, such as GDM, hypertensive disorders, and neonatal complications.
RECENT FINDINGS: Lifestyle modifications, including modest calorie restriction and exercise, improve ovulatory function and pregnancy rates but have limited impact on live-birth rates during fertility treatments. Very low-calorie diets (VLCDs) achieve rapid weight loss but raise concerns about maternal nutrition. Pharmacotherapy offers modest benefits for weight loss and fertility, though teratogenic risks persist. Bariatric surgery often results in significant weight loss and enhanced fertility, yet requires careful timing and management of potential nutrient deficiencies.
SUMMARY: Weight-loss interventions show promise in addressing obesity-related fertility issues, but long-term outcomes and optimal strategies remain unclear. Further research is needed to bridge these gaps and improve reproductive outcomes following weight reduction.

References

  1. Silvestris E, de Pergola G, Rosania R, et al. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol 2018; 16:22.
  2. Sridhar A, Khan D, Moffett RC. The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment. Diabetic Med 2023; 40:e15230.
  3. Boyle BR, Ablett AD, Ochi C, et al. The effect of weight loss interventions for obesity on fertility and pregnancy outcomes: a systematic review and meta-analysis. Int J Gynecol Obstet 2022; 161:335���342.
  4. Gautam D, Purandare N, Maxwell CV, et al. The challenges of obesity for fertility: a Figo literature review. Int J Gynecol Obstet 2023; 160:50���55.
  5. Rubens M, Ramamoorthy V, Saxena A, et al. Obstetric outcomes during delivery hospitalizations among obese pregnant women in the United States. Sci Rep 2022; 12:6862.
  6. Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep 2017; 6:187���194.
  7. Schummers L, Hutcheon JA, Bodnar LM, et al. Risk of adverse pregnancy outcomes by prepregnancy body mass index. Obstet Gynecol 2015; 125:133���143.
  8. van Elten TM, Karsten MD, Geelen A, et al. Preconception lifestyle intervention reduces long term energy intake in women with obesity and infertility: a randomised controlled trial. Int J Behav Nutr Phys Act 2019; 16:3.
  9. Gambineri A, Laudisio D, Marocco C, et al. Female infertility: which role for obesity? Int J Obes Suppl 2019; 9:65���72.
  10. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology���a systematic review. Hum Reprod Update 2007; 13:433���444.
  11. Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update 2017; 23:681���705.
  12. Gaskins AJ. Recent advances in understanding the relationship between long- and short-term weight change and fertility. F1000Research 2018; 7:1702.
  13. Singh N, Stewart RA, Benatar JR. Intensity and duration of lifestyle interventions for long-term weight loss and association with mortality: a meta-analysis of randomised trials. BMJ Open 2019; 9: doi:10.1136/bmjopen-2019-029966. [DOI: 10.1136/bmjopen-2019-029966]
  14. Balen AH, Dresner M, Scott EM, Drife JO. Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ 2006; 332:434���435.
  15. Mutsaerts MAQ, van Oers AM, Groen H, et al. Randomized trial of a lifestyle program in obese infertile women. N Engl J Med 2016; 374:1942���1953.
  16. Einarsson S, Bergh C, Friberg B, et al. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod 2017; 32:1621���1630.
  17. Nelson SM, Fleming R. Obesity and reproduction: impact and interventions. Curr Opin Obstet Gynecol 2007; 19:384���389.
  18. Price SA, Sumithran P. Using a very low energy diet to achieve substantial preconception weight loss in women with obesity: a review of the safety and efficacy. Nutrients 2022; 14:4423.
  19. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007; 107:1755���1767.
  20. Kamrath R, Plummer L, Sadur C, et al. Cholelithiasis in patients treated with a very-low-calorie diet. Am J Clin Nutr 1992; 56:255S���257S.
  21. Kluge L, Bergh C, Einarsson S, et al. Cumulative live birth rates after weight reduction in obese women scheduled for IVF: Follow-up of a randomized controlled trial. Hum Reprod Open 2019; 2019:hoz030.
  22. Morley LC, Tang T, Yasmin E, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2017; 2018:CD003053.
  23. Taghavi SA, van Wely M, Jahanfar S, Bazarganipour F. Pharmacological and non-pharmacological strategies for obese women with subfertility. Cochrane Database Syst Rev 2021; 2021: CD012650.
  24. Wu Y, Tu M, Huang Y, et al. Association of Metformin with pregnancy outcomes in women with polycystic ovarian syndrome undergoing in vitro fertilization. JAMA Network Open 2020; 3: doi:10.1001/jamanetworkopen.2020.11995. [DOI: 10.1001/jamanetworkopen.2020.11995]
  25. McLean BA, Wong CK, Campbell JE, et al. Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation. Endocr Rev 2020; 42:101���132.
  26. Cena H, Chiovato L, Nappi RE. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab 2020; 105:dgaa285.
  27. Cesta CE, Rotem R, Bateman BT, et al. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. Obstet Anesth Digest 2024; 44:200���201.
  28. [Internet]. [Accessed 15 March 2025]. Available from: https://clinicaltrials.gov/study/NCT05872022?tab=results.
  29. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. JAMA 2004; 292:1724.
  30. Mitchell BG. Roux-en-Y gastric bypass. U.S. National Library of Medicine; 2024 [cited 2025 Jan 8]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK553157/.
  31. Felsenreich DM, Prager G. Laparoscopic sleeve gastrectomy: comorbidity outcomes. Obes Bariatric Metab Surg 2021; 1���12. doi:10.1007/978-3-030-54064-7_86-1. [DOI: 10.1007/978-3-030-54064-7_86-1]
  32. Chou J-J, Lee W-J, Almalki O, et al. Dietary intake and weight changes 5 years after laparoscopic sleeve gastrectomy. Obes Surg 2017; 27:3240���3246.
  33. Al-Bader I, Khoursheed M, Al Sharaf K, et al. Revisional laparoscopic gastric pouch resizing for inadequate weight loss after Roux-en-Y gastric bypass. Obes Surg 2015; 25:1103���1108.
  34. Heusschen L, Krabbendam I, van der Velde JM, et al. A matter of timing���pregnancy after bariatric surgery. Obes Surg 2021; 31:2072���2079.
  35. Samarasinghe SN, Leca B, Alabdulkader S, et al. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the Bambini multicentre, open-label, randomised controlled trial. Lancet 2024; 403:2489���2503.
  36. Cheah S, Gao Y, Mo S, et al. Fertility, pregnancy and post partum management after bariatric surgery: a narrative review. Med J Aust 2022; 216:96���102.
  37. Johansson K, Cnattingius S, N��slund I, et al. Outcomes of pregnancy after bariatric surgery. N Engl J Med 2015; 372:814���824.
  38. Ceulemans D, Deleus E, Benhalima K, et al. Pregnancy after metabolic bariatric surgery: risks and rewards for mother and child. BJOG 2024; 132:401���413.
  39. Garc��a D, Brazal S, Rodr��guez A, et al. Knowledge of age-related fertility decline in women: a systematic review. Eur J Obstet Gynecol Reprod Biol 2018; 230:109���118.
  40. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism 2019; 92:6���10.
  41. Ameratunga D, Gebeh A, Amoako A. Obesity and male infertility. Best Pract Res Clin Obstet Gynaecol 2023; 90:102393.
  42. Palmer NO, Bakos HW, Fullston T, Lane M. Impact of obesity on male fertility, sperm function and molecular composition. Spermatogenesis 2012; 2:253���263.
  43. Donkin I, Versteyhe S, Ingerslev LR, et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab 2016; 23:369���378.
  44. Varnum AA, Pozzi E, Deebel NA, et al. Impact of GLP-1 agonists on male reproductive health���a narrative review. Medicina 2023; 60:50.
  45. Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss effects of swemaglutide in obesity without diabetes in the select trial. Nat Med 2024; 30:2049���2057.
Journal Article

Word Cloud

Created with Highcharts 10.0.0fertilityweightoutcomeslossreproductiveimproveObesityovulatoryobesityinsulinresistancediabetesGDMinterventionsrisksmodestratesPURPOSEOFREVIEW:significantlyimpactswomencontributinghormonalimbalancesdysfunctionpoorespeciallypronouncedpolycysticovarysyndromePCOSexacerbatechallengesMoreoverriskfactortype2T2DgestationalcomplicatinghealthEffectiveconceptionessentialreduceadverseperinatalhypertensivedisordersneonatalcomplicationsRECENTFINDINGS:Lifestylemodificationsincludingcalorierestrictionexercisefunctionpregnancylimitedimpactlive-birthtreatmentslow-caloriedietsVLCDsachieverapidraiseconcernsmaternalnutritionPharmacotherapyoffersbenefitsthoughteratogenicpersistBariatricsurgeryoftenresultssignificantenhancedyetrequirescarefultimingmanagementpotentialnutrientdeficienciesSUMMARY:Weight-lossshowpromiseaddressingobesity-relatedissueslong-termoptimalstrategiesremainunclearresearchneededbridgegapsfollowingreductionfertility:unresolvedquestionsemerginginsights

Similar Articles

Cited By

No available data.